Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-06-07 Nicholson John SVP & Chief Operating Officer Sale −101,700 $19.24 $2.0M 227,243
2017-06-07 Nicholson John SVP & Chief Operating Officer Exercise or conversion · Stock Option −150,000 0
2017-05-16 Thomsen Jillian B. SVP & Chief Accounting Officer Sale −2,651 $19.55 $52K 52,986
2017-05-16 ROBIN HOWARD W President & CEO Sale −8,388 $19.55 $164K 160,884
2017-05-16 Nicholson John SVP & Chief Operating Officer Sale −3,146 $19.55 $62K 178,943
2017-05-16 Labrucherie Gil M SVP & Chief Financial Officer Sale −3,179 $19.55 $62K 66,091
2017-05-16 Hora Maninder SVP Pharma Dev & Mfg Ops Sale −2,959 $19.55 $58K 60,689

Page 43 of 43 · 847 trades